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Abstract
Background: Injection of biomaterial to suburetral region, using minimally invasive procedure, has become an
interesting topic for urologists to treat vesicoureteral reflux. The objective of this study was to evaluate the
feasibility of injecting newly introduced calcium hydroxyl apatite to suburetral region, for treating an experimentally
induced vesicoureteral reflux in dogs.
Findings: Bilateral vesicoureteral refluxed (VUR) mixed breed dogs (n = 12; 10-15 kg live weight, 3-6 months of
age) were selected for this study. The presence and grade of the reflux were determined using cystography.
Accordingly, 6 dogs displayed grade 1 & 2 and the other 6 showed grade 3 & 4 bilateral VUR. Every single dog,
with bilateral VUR, underwent endoscopic treatment and received an injection of calcium hydroxyl apatite (an
Iranian made product) into the left (treated side) and an injection of the similar volume of normal saline in to the
right (control side) subureteric space. One week, 3 and 6 months after treatment, cystography was performed. On
each occasion, 4 dogs were euthanized by gas inhalation and biopsy samples were collected for histopathological
study from ureter, bladder, kidney, lung and spleen in order to investigate the biomaterial migration into different
organs. Data were analyzed using Chi-squared test. In control sides, radiographs confirmed the same grade of VUR,
found at the initiation of the study. VUR was resolved in 100% (6/6) of Grade 1 & 2 and 83.33% (5/6) of Grade 3 &
4 in treated side. Therefore, the total success rate of this study was 91.67% (11/12). Macroscopic examination of the
vesicouretral region of the treated side revealed a firm and consistent biomaterial mass at the site of injection.
Histological findings confirmed inflammation at treated side. In contrast, there was no tissue reaction on control
side. There was no evidence for biomaterial migration in macroscopic and microscopic observations in this study.
Conclusion: In the present study, a new biocompatible material produced a firm, consist and sustainable
biomaterial mass in the suburetral region for treating vesicouretral reflux without any evidence of biomaterial
migration.
Findings
Application of Biomaterials for treating vesicoureteral
reflux is not fully elucidated [1-3]. Primary vesicouret-
eral reflux is considered as a congenital defect resulting
from a short intramural ureteral tunnel and an absence
of adequate detrussor behind the intravesical ureter
[1,4-7]. Reflux is usually discovered during radiological
investigation in 30-50% of children referred with urinary
tract infection and the treatment is either medical or
surgical [2]. Medical approach may be able to resolve a
low-grade reflux, but surgical intervention is required in
a complicated reflux with dilated ureter. The minimally
invasive procedures, like sub-ureteral injection of biode-
gradable and biocompatible materials, have become the
treatment of choice for reflux in some centers. The suc-
cess of injecting biomaterials into sub-ureteral region
depends on the experience of the surgeon to identify
the ureteral orifice [8]. This approach is indicated for
patients with poor prophylactic compliance, after failed
ureteral reimplantation, in children with naturopathic
bladder dysfunction, in those that open surgical techni-
ques are less likely to produce a successful result and in
persistent reflux after complicated augmentation or
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the endoscopic correction of VUR is to create a solid
support behind the intravesical ureter by endoscopic
injection of biomaterial, in order to elongate the intera-
mural part of the ureter. This method is simple and can
be completed in less than 15 minutes [1,3,5]. The sub-
ureteric injection method for reflux was first reported in
1981 [4]. The endoscopic treatment was popularized in
the mid-to-late 1980s and became known as the subure-
teric Teflon injection called STING. Biomaterials used
f o rt h i sp u r p o s e ,h a v et ob eb i o c o m p a t i b l e ,n o n - t o x i c
and unable to migrate to other organs. Research is con-
centrated on elucidating the quantity of the biomaterial,
the site of injection, local reaction and potential migra-
tion to distant organs. Many natural materials have been
tested experimentally with advantages and disadvantages
[3,11-13]. The objective of this study was to investigate
the effect of the newly introduced biomaterial, calcium
hydroxyl apatite (an Iranian made product), on treating
experimentally induced vesicoureteral reflux, using mini-
mally invasive procedure, in dogs.
The present study was approved by the ethics com-
mittee of Faculty of Veterinary Medicine, University of
Tehran (BNS714/12.03.07). Healthy dogs (n = 12),
weighting 10-15 kg and aged between 3 to 6 months
were selected and kept under standard management
condition. Rigid cystoscope 13 Fr (3 Fr. Working chan-
nel) sheath was used to pass into urethra.
In order to induce reflux, the bladder was exposed
extraperitoneally through midline incision, and the uret-
eral orifices were identified and catheterized with 3Fr
ureteral stent and reflux was induced by slitting the
anterior roof of both intramural ureters for 5-7 mm.
The mucosa of ureter and bladder were sutured to each
other with 3/0 nylon suture material. Then, the ureteral
catheters were removed and bladder was closed with 3/0
absorbable suture material in a routine two layer man-
ner [14,15]. One month after inducing reflux, cystogra-
phy was carried out under light general anesthesia to
confirm the vesicoureteal reflux. Meglumine compound
was allowed to run into the bladder until complete dis-
tention of bladder achieved. X-ray was taken in lateral
and ventrodorsal positions. One month after inducing
reflux, endoscopic treatment was performed by calcium
hydroxyl apatite (an Iranian made product; Figure 1).
The presence and grade of the reflux were determined
prior to endoscopy using cystography. Accordingly, dogs
were classified to have Grade 1 (n = 3), Grade 2 (n = 3),
Grade 3 (n = 3) and Grade 4 (n = 3) bilateral VUR.
Every single dog, with bilateral VUR, underwent endo-
scopic treatment and received an injection of calcium
hydroxyl apatite (an Iranian made product) into the left
(treated side) and an injection of the similar volume of
normal saline in to the right (control side) subureteric
space (Figure 2). The injected volume was 0.4 - 0.6 ml.
Mean particle size of calcium hydroxyl apatite was 10.28
(8.31-14.12) um. Once the particles being dissolved and
aggregated with autologous serum, it could become as
large as 70-120 um. For preparation of this biomaterial
the use of glycolic acid, hylorunic acid and any other
chemical agents is not necessary.
One week, 3 and 6 months after treatment, cystogra-
phy was performed. On each occasion, 4 dogs were
euthanized by gas inhalation and biopsy samples were
collected for histopathological study from ureter, blad-
der, kidney, lung and spleen in order to investigate the
biomaterial migration into different organs. Data were
analyzed using Chi-squared test.
In the present study, reflux was successfully induced
in all animals. Following inducing reflux, temperature,
pulse and respiration rate were in the normal range.
H o w e v e r ,b l o o dt i n g e di nt h eu r i n ei nt h ef i r s td a ya n d
depression and anorexia for few days after treatment
were noted which seemed to be expected for such pro-
cedures. Dogs return to normal feed few hours after
inducing reflux. Endoscopy performed one month after
Figure 1 Cystogram showing induced bilateral reflux.
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tion. After conformation of reflux, endoscopic injections
of normal saline and calcium hydroxyl apatite into the
subureteric space were conducted without any complica-
tions such as urine retention or urethral obstruction.
Radiographs obtained one week, 3 and 6 months after
treatment confirmed the same grade of VUR in control
sides. However, VUR was resolved in 100% (6/6) of Grade
1&2a n d8 3 . 3 3 %( 5 / 6 )o fG r a d e3&4i nt r e a t e ds i d e .
Therefore, the total success rate in this study was 91.67%
(11/12) for treated sides compared to 0% (0/12) for control
sides (P < 0.01). Macroscopic examination of the vesi-
couretral region of the treated side revealed a firm and
consistent biomaterial mass at the site of injection.
Histological findings following the first week after
treatment revealed inflammation, collagen formation,
edema and/or fibrosis of the ureter or bladder wall at
treated side (Figure 3, 4, 5 and 6). There was no tissue
reaction on control side. There was no evidence for bio-
material migration in macroscopic and microscopic
observations in this study.
All urine cultures for the 12 dogs of bilateral reflux
were sterile throughout the study. No migration of bio-
material was found in other organ. There was no resi-
due of calcium hydroxyl apatite in different samples
obtained from different organs. After 6 months, the
gross appearance of injection sites revealed well circum-
scribed as elevation of the mucosa without any overlying
erythema, fibrosis or ulceration. Gross examination of
the vesicoureteric region showed a well circumscribed,
firm and consistent subureteric calcium hydroxyl apatite
mass, retaining its shape and position.
The purpose of this study was to evaluate the safety,
efficacy, local tissue reaction and possible migration of
new calcium hydroxyl apatite to treat dogs with induced
reflux using endoscopic intervention. The procedure of
inducing VUR used in this study was the same as the
p r o c e d u r eu s e dp r e v i o u s l yi np i g sb ys l i t t i n gt h ea n t e -
rior roof intramural ureters followed by suturing
[16-18]. The endoscopic correction of VUR has become
widely accepted as a standard procedure to many spe-
cialists [11]. The main concern in using biomaterials is
not the procedure of injection. In the present study,
injection of the biomaterial was simple and fast proce-
dure which was comparable to the result of other
Figure 2 Cystogram showing endoscopic treated side with
calcium hydroxyl apatite.
Figure 3 Bladder wall showing sedimentation of calcium
hydroxyl apatite (H & E×100).
Figure 4 Small violet granules of calcium hydroxyl apatite in
the site of injection (H & E×400).
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quality and safety of biomaterials and to avoid the
potential danger of injecting foreign materials [20].
Many materials such as blood, fat and cartilage have
been tested experimentally [1,3,4]. One of the main
concern in using biomaterials is the migrations of these
materials to other organs, like muscle layer and/or sub-
mucosal layer of urinary bladder, spleen and lung which
have been reported following endoscopic treatment of
urethral reflux in dogs, rabbits and human [3,18,21-23].
Therefore, long term follow up seems necessary to
approve the efficacy of different biocompatible materials
used in VUR treatments. In the present study, after 6
months, there was no evidence of migration of calcium
hydroxyl apatite from the injected site to other organs.
Similar result, but not for long term, was found using
iodine labeled Dextranomer based implant [22]. The
volume of injected material was 0.4-0.6 ml in the pre-
sent study with high success rate (91.67%). In other stu-
dies, less volume of biomaterials (0.1-0.4 ml) was used
[11,12,21] but the success rate was lower than the pre-
sent study (53%; 11).
Conclusion
An Iranian made calcium hydroxyl apatite, which is
extremely less expensive than commercially available
biomaterials, was efficient to correct reflux without any
evidence of complications. Further investigation is
required to evaluate this biomaterial for human.
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